| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2544117 | Journal of the American Pharmacists Association | 2006 | 12 Pages |
Abstract
The debate over a follow-on process likely will be difficult as parties seek a balance between incentives for biopharmaceutical innovation, consumer safety, and affordability of existing biologic products.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Devine PharmD, BCPS, Cline PhD, Farley BPharm,